Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

AQSTAQST
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in AQUESTIVE THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 468,569 shares of AQST (AQUESTIVE THERAPEUTICS INC), worth $1.9M as of 2026-Q2. The position was increased (+0.4% shares). AQST represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$1.9M

Current Shares

468,569

Total Value Change

-$1.2M

Total Shares Change

-407,968

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
468,569
+0.4%
$1.9M0.0%$4.16
26
2026-Q1
Decreased
466,767
-48.6%
$1.9M0.0%$4.12
0
2025-Q4
Increased
909,064
+130.1%
$5.9M0.0%$6.38
44
2025-Q3
Decreased
395,150
-24.7%
$2.2M0.0%$5.65
0
2025-Q2
Decreased
524,685
-35.9%
$1.7M0.0%$3.25
0
2025-Q1
Decreased
818,849
-6.6%
$2.4M0.0%$3.02
0
2024-Q4
New
876,537
-
$3.1M0.0%$3.52
37

Other major holders of AQST: BlackRock, Inc., RTW INVESTMENTS, LP, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used